Active	Status	Sponsor type	Region	Phase	Filter
14 Active 17 Inactive 31 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hsue, Priscilla
PREVAIL-LC, NCT06161688: Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID	Active, not recruiting	2	40	US	Ensitrelvir, ensitrelvir fumaric acid, Placebo	Timothy Henrich, Shionogi Inc.	Long COVID, Post Acute Sequelae of COVID-19, Post-Acute COVID-19	06/25	12/25
Graf, Jonathan
NAV3-33, NCT05246280: Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RA	Terminated	3	196	US	TC99m-tilmanocept, tilmanocept, Lymphoseek	Navidea Biopharmaceuticals	Rheumatoid Arthritis	07/24	07/24
NCT06153095: A Study of IMPT-514 in Active Refractory Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)	Recruiting	1/2	30	US, RoW	IMPT-514	ImmPACT Bio	Systemic Lupus Erythematosus, Lupus Nephritis	02/27	02/27
Carvidi, Alex
NAV3-33, NCT05246280: Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RA	Terminated	3	196	US	TC99m-tilmanocept, tilmanocept, Lymphoseek	Navidea Biopharmaceuticals	Rheumatoid Arthritis	07/24	07/24
NCT06201416: Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis	Recruiting	1	24	US	SBT777101	Sonoma Biotherapeutics, Inc.	Rheumatoid Arthritis	03/26	03/26